Comparing different NSAIDs plus home exercises for frozen shoulder
Official title: Comparative Efficacy of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) With Distinct Chemical Structures in Shoulder Adhesive Capsulitis and the Role of Pain Phenotypes
Run by Konya Beyhekim Training and Research Hospital · NCT07493226 · Data updated 2026-11-12
This will test whether taking one of several NSAIDs (diclofenac, meloxicam, or indomethacin) together with home shoulder exercises helps adults aged 18–75 with frozen shoulder and whether pain type changes the benefit.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Konya Beyhekim Training and Research Hospital Government |
| Locations | 1 site (Konya, Selçuklu) |
| Status | Recruiting |
| Started | April 1, 2026 |
| Main results expected | February 28, 2027 |
| Study ends | March 30, 2027 |
| Registry record updated | May 14, 2026 |
| Trial ID | NCT07493226 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–75 with primary frozen shoulder, at least one month of shoulder pain, VAS ≥4/10, and ≥30° restriction in two or more planes who can attend clinic visits and provide informed consent are ideal candidates.
✕Probably not a fit
Patients with secondary shoulder problems such as rotator cuff tear, shoulder arthritis, prior shoulder surgery or manipulation, recent trauma, neurologic disorders, malignancy, or other listed exclusion criteria are unlikely to be eligible or to benefit from this specific protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults aged 18–75 with primary frozen shoulder and at least one month of shoulder pain will be enrolled at Konya Beyhekim Training and Research Hospital and randomized to receive one of several NSAIDs (diclofenac, meloxicam, or indomethacin) alongside a home-based shoulder exercise program. Investigators will record sociodemographic data, detailed clinical and examination findings, imaging where relevant, and baseline outcome measures before treatment. Patients' pain phenotypes will be classified as nociceptive, neuropathic, or nociplastic using clinical history and questionnaires, and block randomization will assign about 120 participants to chemically distinct NSAID groups. Outcomes will compare pain, range of motion, and function across drug groups and pain phenotypes to identify which combinations produce greater symptom improvement.
Why it matters
Potential benefit: If successful, the results could help clinicians choose the best NSAID and exercise plan for people with frozen shoulder based on their pain type, improving pain relief and shoulder movement.
How similar studies have gone: NSAIDs plus exercise are commonly used and have shown symptom benefit in frozen shoulder, but directly comparing chemically distinct NSAIDs and linking response to nociceptive/neuropathic/nociplastic phenotypes is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Being between 18-75 years of age 2. Having shoulder pain that has lasted for at least one month and being diagnosed with primary frozen shoulder 3. Having a VAS pain level ≥ 4/10 4. Having ≥30 degrees of range of motion restriction in at least two planes (flexion, abduction, or external rotation) 5. Not having any exclusion criteria and agreeing to participate in the study voluntarily Exclusion Criteria: 1. Patients with a history of shoulder trauma, those with musculoskeletal disorders characterized by pain and loss of function in the affected extremity (such as lateral epicondylitis, flexor tendon injury, de Quervein's tenosynovitis) 2. Presence of neurological involvement such as stroke, brachial plexus injury, Parkinson's disease, and cervical spine injury with or without radiculopathy 3. History of shoulder surgery, malignancy or tumor in the shoulder, those who have undergone shoulder manipulation 4. Presence of shoulder arthritis, rotator cuff tear or other shoulder injuries, thoracic outlet syndrome 5. Systemic disease affecting the shoulder region, severe degeneration or trauma (e.g., osteoarthritis, rheumatoid arthritis, history of labrum or articular cartilage injuries), inflammatory rheumatic diseases 6. Those who have received steroid injections into the affected extremity within the last 3 months, those using oral steroids or NSAIDs, those receiving any surgical or interventional treatment, or Planned individuals: 7. Those who are pregnant or lactating 8. Those with uncontrolled diabetes, heart failure, uncontrolled systemic disease (liver disease, chronic kidney failure, significant endocrine disorders, etc.) 9. Those with communication problems, severe psychiatric disorders 10. Those allergic to NSAIDs or with any contraindications 11. Those with bleeding, coagulation disorders, stomach ulcers, or symptomatic gastritis
Where it's running
-
Konya Beyhekim Training and Research Hospital
Konya, Selçuklu, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Rukiye Hilal Taygurt Md., principal investigator
- Email: rukiyehilalgokce@gmail.com
- Phone: +905389122141
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ultrasound-guided shoulder injections for frozen shoulder
This tests whether adding ultrasound-guided suprascapular nerve block, with or without a subacromial injection, to a home exercise program reduces pain and improves shoulder function in adults with chronic frozen shoulder.
-
Spinal and Kaltenborn mobilization for a stiff shoulder (frozen shoulder)
A randomized trial tests spinal mobilization with arm movement and Kaltenborn mobilization to see if they reduce pain and improve motion and function in people with adhesive capsulitis.
-
Shoulder Frozen Shoulder: TAME vs Corticosteroid Injection
This study tests whether transcatheter arterial microembolization (TAME) works better than corticosteroid injections for people with frozen shoulder.
-
Electrophysiologic effects of 360° capsular release for frozen shoulder
We will test whether arthroscopic 360° capsular release causes measurable changes in axillary and musculocutaneous nerve function in adults (21–70) with frozen shoulder who haven't improved with conservative care.
-
High-intensity interval training for persistent inflammatory shoulder pain
This study will try short sessions of high-intensity interval training (HIIT) in adults with long-term shoulder pain thought to be driven by low-grade inflammation to see if the exercise is acceptable and whether inflammation and pain-related measures change.
-
Home-use brain stimulation (tDCS) for chronic neuropathic or nociplastic pain
This trial will test whether using a home tDCS device for 12 weeks can reduce pain in people with chronic neuropathic or nociplastic pain who had only short-term relief from rTMS.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.